Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

Glenmark concludes post marketing surveillance study on Favipiravir (FabiFlu®) in 1000+ COVID-19 patients

Posted On: 2021-09-15 05:23:01 (Time Zone: UTC)


Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today announced the successful completion of its Post Marketing Surveillance (PMS) study on Favipiravir (FabiFlu®) in India. The PMS study commenced in July 2020 to evaluate the safety and efficacy of Favipiravir in mild to moderate COVID-19 patients. A total of 1083 patients were enrolled in the prospective, open label, multicentre, single arm study. Results showed no new safety signals or concerns with the use of Favipiravir, and already-known side effects such as weakness, gastritis, diarrhoea, vomiting etc., were found to be mild in nature. The time for fever resolution was 4 days, while time for clinical cure was 7 days.

Glenmark's PMS study is the first and largest post marketing study conducted in India on Favipiravir in mild to moderate COVID-19 patients. Thirteen sites - both Government and private institutions - across Mumbai, Bangalore, Hyderabad, Nashik, Nagpur, and Trivandrum took part. The study was conducted in patients in line with the approved indication of the drug.

Commenting on these findings, Mr. Alok Malik, Group Vice President & Head, India Formulations, said, "This study was crucial as it examined the safety and efficacy of FabiFlu® in real-world settings, where multiple variables can impact the results. Despite these factors, the PMS study demonstrated FabiFlu®'s consistent ability to provide symptomatic relief and improve clinical outcomes in patients with mild to moderate COVID19. It is a step forward both for Glenmark and the medical community, as it reinforces the oral antiviral's multiple benefits in tackling the pandemic."

On June 19, 2020, Glenmark became the first company in India to receive restricted emergency use approval from India's drug regulator for Favipiravir (FabiFlu®), making it the first oral Favipiravir-approved medication in India for the treatment of mild to moderate COVID-19. The approval was granted as part of accelerated approval process, considering the emergency situation of the COVID-19 outbreak in India.

This PMS study continued to evaluate the safety and efficacy of Favipiravir (FabiFlu®) post its launch in the market. The average age of patients in the study was 40 years, with women comprising 40%, while men 60% of the study population. Hypertension (11%) and diabetes (8%) were the two most common comorbidities noted in these patients. Fever was present in all patients at baseline, followed by cough (81%), fatigue (46.2%), and new loss of taste (41%).

Shares of Glenmark Pharmaceuticals ltd was last trading in BSE at Rs. 531.55 as compared to the previous close of Rs. 518.95. The total number of shares traded during the day was 100884 in over 3800 trades.

The stock hit an intraday high of Rs. 533.45 and intraday low of 520. The net turnover during the day was Rs. 53079057.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Other Headlines:

Intellect launches Capital Cube 21, a Contextual Treasury Platform fueled by Composable Next Gen Technology

IndusInd Bank spreads joy among underprivileged children this festive season

Rare Asset Reconstruction Ltd acquires financial assets of Impex Ferro Tech Limited from SBI

WardWizard Innovations & Mobility Ltd. to double the production capacity by October 2021

InterGlobe Technology Quotient and EaseMyTrip announce agreement worth $10 million

Birlasoft Solution achieves Oracle Validated Integration with JD Edwards EnterpriseOne Expertise for Delivering Proven, Repeatable Integration

Gokul Agro Resources Limited wins Globoil Rising Star of the Year 2021 award

Nucleus Software's PaySe passes RBI's Regulatory Sandbox

Ind-Ra upgrades rating of Happiest Minds Technologies Ltd

Kreon Finnancial Services Ltd updates on business performance

IndusInd Bank partners with Vistara to launch a co-branded credit card

Patel Engineering bags new order of Rs. 1251 crore Teesta-VI Hydro Electric Project

Renaissance Global establishes Strategic Advisory Board

Mindtree Recognized by Great Place to Work® as one of India's Best Workplaces™ for Women 2021

Manali Petrochemical Ltd to partner with Econic, UK for new Polyol Technology

Goa Carbon Ltd shuts down Bilaspur Unit, Goa Unit for maintenance work

Government of India announces India's airspace map for Drones operations

Astrazeneca Pharma India Ltd receives import and market permission for Selumetinib 10 Mg & 25 Mg Capsule

Spirit of Wipro Run brings together participants from 35 countries

Federal Bank partners with Ashok Leyland

Kotak Mahindra Bank forays into Healthcare Financing

Puravankara announces Credit Rating Upgrade by India Ratings and Research

Pay your Tata Power-DDL Bill before September 30 and stand a chance to Win Exciting Prizes

Kotak Launches Kotak Shiksha Nidhi - Financial Assistance to Students, who have lost a Primary Earning Member to COVID-19, for the Continuation of Education

Mr. Sankarshan Basu and Mr. Ramanand Mundkur Join Federal Bank's Director Board

Vedanta Jharsuguda's Power Plants awarded as 'Best Water-Efficient Plants'

PG Electroplast applies for the PLI scheme, commits Rs 300 crore Capex

Radico Khaitan signs Nidhi Agerwal as their brand influencer for Morpheus Brandy

IndianOil Corporation Collaborates with Automation Anywhere to Accelerate Automation

Federal Bank partners with OneCard to offer mobile-first Credit Card

Newgen Recognized in 2021 Gartner Magic Quadrant for Enterprise Low-Code Application Platforms for Second Year in a Row

Reliance Infrastructure Limited board approves FCCB issue, to convert into shares at Rs. 111

Reliance Power Limited appoints Shri Subrajit Bhowmick as CFO

HDFC has sold 2.13% stake in Ansal Housing Ltd

Aditya Birla Sun Life AMC reserves 1,944,000 shares to shareholders of Aditya Birla Capital Ltd

IndusInd Bank Ltd has sold 6,30,733 Equity shares of McLeod Russel India Ltd

Zeal Aqua Ltd fixes Oct 19, 2021 as record date for stock split

Mangal Credit & Fincorp Limited launches channel partners for gold loan

IRB Infrastructure Developers Ltd receives LoA from NHAI for road project in Tamil Nadu

Reliance Infrastructure Ltd appoints Shri Sandeep Khosla as CFO

PB Fintech Ltd withdraws from merger with Makesense Technologies Ltd

Avi Products India Ltd receives approval from BSE for preferential issue

TVS Srichakra Limited to participate in rights issue of TVS Srichakra Investments Ltd

Biocon Biologics Insulin Manufacturing Facility in Malaysia Completes U.S. FDA (PAI) Inspection

PNB shortlists Alankit Ltd as National Business Correspondent

Balkrishna Industries Limited to raise Rs. 1000 crores

CRISIL upgrades long term rating of Nahar Spinning Mills Ltd

Mr. Sujay Wasan resigns as Director of Procter & Gamble Health Limited

InterGlobe Aviation Ltd updates on arbitral award

B N Rathi Securities Limited board approves rights issue


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020